These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31729755)

  • 21. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
    So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
    Tisch R; Liblau RS; Yang XD; Liblau P; McDevitt HO
    Diabetes; 1998 Jun; 47(6):894-9. PubMed ID: 9604865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
    Allen JS; Pang K; Skowera A; Ellis R; Rackham C; Lozanoska-Ochser B; Tree T; Leslie RD; Tremble JM; Dayan CM; Peakman M
    Diabetes; 2009 Jan; 58(1):138-45. PubMed ID: 18835928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat.
    Ellerman KE; Like AA
    Diabetes; 1999 May; 48(5):975-82. PubMed ID: 10331400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
    Dotta F; Eisenbarth GS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse.
    Reddy S; Wu D; Swinney C; Elliott RB
    Pancreas; 1995 Jul; 11(1):16-25. PubMed ID: 7667242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of distinct islet protein autoantigens associated with type 1 diabetes.
    Christie MR
    Autoimmunity; 1993; 15 Suppl():1-3. PubMed ID: 8218841
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoantibodies in human diabetes.
    Pietropaolo M; Eisenbarth GS
    Curr Dir Autoimmun; 2001; 4():252-82. PubMed ID: 11569406
    [No Abstract]   [Full Text] [Related]  

  • 30. Histological changes of the pancreas in an elderly diabetic patient positive for GAD antibody.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 2000 Dec; 39(12):1079-82. PubMed ID: 11197795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet cell autoantibodies: pathobiology and clinical applications.
    Vardi P; Dibella EE; Pasquarello TJ; Srikanta S
    Diabetes Care; 1987; 10(5):645-56. PubMed ID: 3315517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet Autoantibodies.
    Lampasona V; Liberati D
    Curr Diab Rep; 2016 Jun; 16(6):53. PubMed ID: 27112957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenesis of insulin-dependent diabetes mellitus.
    Atkinson MA; Maclaren NK
    N Engl J Med; 1994 Nov; 331(21):1428-36. PubMed ID: 7969282
    [No Abstract]   [Full Text] [Related]  

  • 38. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited.
    Harrison LC
    Immunol Today; 1992 Sep; 13(9):348-52. PubMed ID: 1466752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus.
    Bach JF
    Clin Rev Allergy Immunol; 2000 Dec; 19(3):217-25. PubMed ID: 11138406
    [No Abstract]   [Full Text] [Related]  

  • 40. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.